Upendra Bulbake

Biomaterials · 2017

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Upendra Bulbake trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Y. Barenholz
  2. F. Danhier

Papers from Upendra Bulbake's perspective

Ordered by how strongly the researchers Upendra Bulbake trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Liposome application: problems and prospects
  2. Pharmacokinetics of Pegylated Liposomal Doxorubicin (Clinical Pharmacokinetics)
  3. Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy (International Journal of Nanomedicine)
  4. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. (Journal of Controlled Release)
  5. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential (International Journal of Nanomedicine)
  6. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group. (Journal of Clinical Oncology)
  7. Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial. (The Lancet)
  8. To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine? (Journal of Controlled Release)
  9. Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors (Proceedings of the National Academy of Sciences of the United States of America)
  10. Transport of molecules across tumor vasculature (Cancer Metastasis Review)

Their papers